New Pre-Surgery combo could boost survival in tough head & neck cancers
NCT ID NCT07371897
Summary
This study is for people with advanced head and neck cancer that hasn't spread. It compares two short drug treatments given before surgery to see which one is better at keeping the cancer from coming back. Patients will get either an immunotherapy drug alone or that same drug plus two cycles of standard chemotherapy. Everyone will then have surgery followed by radiation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA HNSCC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.